A detailed history of Quarry LP transactions in Natera, Inc. stock. As of the latest transaction made, Quarry LP holds 654 shares of NTRA stock, worth $133,599. This represents 0.02% of its overall portfolio holdings.

Number of Shares
654
Previous 756 13.49%
Holding current value
$133,599
Previous $128 Million 17.57%
% of portfolio
0.02%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$133.66 - $181.11 $13,633 - $18,473
-102 Reduced 13.49%
654 $105 Million
Q2 2025

Aug 14, 2025

BUY
$132.23 - $171.87 $83,304 - $108,278
630 Added 500.0%
756 $128 Million
Q1 2025

May 15, 2025

BUY
$132.63 - $177.0 $3,183 - $4,248
24 Added 23.53%
126 $17.8 Million
Q4 2024

Feb 14, 2025

BUY
$117.67 - $174.0 $12,002 - $17,748
102 New
102 $16.1 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $16,203 - $21,394
190 Added 148.44%
318 $34.4 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $7,578 - $11,891
128 New
128 $11.7 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.